Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions

Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph Disease, is a progressive neurodegenerative disorder characterized by loss of neuronal matter due to the expansion of the CAG repeat in the ATXN3/MJD1 gene and subsequent ataxin-3 protein. Although the underlying pathogenic protein e...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Anna S. Sowa, Eva Haas, Jeannette Hübener-Schmid, Axel Lorentz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Subjects:	ataxin-3 MJD SCA3 mast cell cytokine neurodegeneration
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.870966/full

Similar Items

Pathogenesis of SCA3 and implications for other polyglutamine diseases
by: Hayley S. McLoughlin, et al.
Published: (2020-02-01)

Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model
by: Piotr Piasecki, et al.
Published: (2023-03-01)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
by: Stefan Hauser, et al.
Published: (2022-03-01)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
by: Ana F. Ferreira, et al.
Published: (2023-05-01)

Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model
by: Ajayi Abiodun, et al.
Published: (2012-07-01)

Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3
by: Zhenchu Tang, et al.
Published: (2023-07-01)

Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3
by: Chang Liu, et al.
Published: (2025-09-01)

A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats
by: Jana Boy, et al.
Published: (2010-02-01)

The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using Drosophila melanogaster mutants
by: Rita Sousa e Silva, et al.
Published: (2023-03-01)

<i>Drosophila</i> as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3
by: Sean L. Johnson, et al.
Published: (2022-04-01)

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3
by: Maria-Efstratia Tsimpanouli, et al.
Published: (2022-10-01)

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis
by: Marilena Lauerer, et al.
Published: (2025-07-01)

Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: Conclusions from double-transgenic mouse models
by: Jeannette Hübener, et al.
Published: (2010-04-01)

An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model
by: Gourango Talukdar, et al.
Published: (2025-04-01)

Spinocerebellar Ataxia 3 (SCA3) Patient with Peripheral Neuropathy
by: Siti Aminah Sobana, et al.
Published: (2022-03-01)

Nystagmus may be the first neurological sign in early stages of spinocerebellar ataxia type 3
by: Maria Thereza Drumond Gama, et al.
Published: (2021-01-01)

Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease
by: Mafalda Raposo, et al.
Published: (2024-04-01)

HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
by: An-Hsun Chou, et al.
Published: (2011-02-01)

The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
by: Yun Peng, et al.
Published: (2022-07-01)

RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1
by: Megan S. Keiser, et al.
Published: (2013-08-01)

Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation
by: Amanjot Singh, et al.
Published: (2021-03-01)

Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3
by: Sean L. Johnson, et al.
Published: (2019-12-01)

Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families
by: Hélio A. G. Teive, et al.
Published: (2012-01-01)

Modest Reduction in CAG Repeat Length Rescues Motor Deficits but Not Purkinje Cell Pathology and Gliosis in Spinocerebellar Ataxia Type 1 Mice
by: Stephen Gilliat, et al.
Published: (2023-03-01)

Cerebellar neuronal dysfunction accompanies early motor symptoms in spinocerebellar ataxia type 3
by: Kristin Mayoral-Palarz, et al.
Published: (2022-08-01)

On the identification of potential novel therapeutic targets for spinocerebellar ataxia type 1 (SCA1) neurodegenerative disease using EvoPPI3
by: Sousa André, et al.
Published: (2023-02-01)

Ataxin-3 and its E3 partners: Implications for Machado-Joseph disease
by: Thomas M Durcan, et al.
Published: (2013-05-01)

Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia
by: David J. Arpin, et al.
Published: (2025-09-01)

Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1)
by: Katherine Hamel, et al.
Published: (2024-07-01)

Supratentorial and Infratentorial Lesions in Spinocerebellar Ataxia Type 3
by: Po-Shan Wang, et al.
Published: (2020-03-01)

Progressive subcortical involvement as spinocerebellar ataxia type 3 advances
by: Pubing Yuan, et al.
Published: (2025-06-01)

Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice
by: Juao-Guilherme Rosa, et al.
Published: (2022-10-01)

Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex
by: Kimberly Luttik, et al.
Published: (2022-08-01)

Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients
by: S T Camargos, et al.
Published: (2011-01-01)

Epilepsy as the symptom of a spinocerebellar ataxia 13 in a patient presenting with a mutation in the KCNC3 gene
by: Shao Li, et al.
Published: (2023-06-01)

Case report: Short-term efficacy and changes in 18F-FDG-PET with acute multi-target stimulation in spinocerebellar ataxia type 3 (SCA3/MJD)
by: Zhiqiang Cui, et al.
Published: (2023-09-01)

Cognition in trinucleotide repeat spinocerebellar ataxias: A review
by: Ayush Agarwal, et al.
Published: (2022-01-01)

BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1
by: Juao-Guilherme Rosa, et al.
Published: (2023-03-01)

Extra-Cerebellar Signs and Non-motor Features in Chinese Patients With Spinocerebellar Ataxia Type 3
by: Xiaoqin Yuan, et al.
Published: (2019-02-01)

A positive feedback loop linking enhanced mGluR function and basal calcium in spinocerebellar ataxia type 2
by: Pratap Meera, et al.
Published: (2017-05-01)